These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30556939)

  • 1. The efficacy and safety of fluticasone/salmeterol compared to fluticasone in children younger than four years of age.
    Yoshihara S; Tsubaki T; Ikeda M; Lenney W; Tomiak R; Hattori T; Hashimoto K; Soutome T; Kato S
    Pediatr Allergy Immunol; 2019 Mar; 30(2):195-203. PubMed ID: 30556939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA.
    Bernstein D; Andersen L; Forth R; Jacques L; Yates L
    J Asthma; 2018 Sep; 55(9):984-993. PubMed ID: 28961020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-week open-label, randomized, controlled trial and 24-week extension to assess the efficacy and safety of fluticasone propionate/formoterol in children with asthma.
    Emeryk A; Klink R; McIver T; Dalvi P
    Ther Adv Respir Dis; 2016 Aug; 10(4):324-37. PubMed ID: 27185164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
    Lee YS; Lin HC; Huang CD; Lee KY; Liu CY; Yu CT; Wang CH; Kuo HP
    Chang Gung Med J; 2011; 34(4):382-94. PubMed ID: 21880193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life.
    Price DB; Williams AE; Yoxall S
    Respir Res; 2007 Jul; 8(1):46. PubMed ID: 17610727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.
    Sher LD; Yiu G; Sakov A; Liu S; Caracta CF
    Allergy Asthma Proc; 2017 Sep; 38(5):343-353. PubMed ID: 28639542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies.
    Siler TM; Kerwin E; Singletary K; Brooks J; Church A
    COPD; 2016; 13(1):1-10. PubMed ID: 26451734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of fluticasone propionate/formoterol compared with fluticasone propionate/salmeterol in treating pediatric asthma: a systematic review and meta-analysis.
    Guan R; Liu Y; Ren D; Li J; Xu T; Hu H
    J Int Med Res; 2020 Mar; 48(3):300060519889442. PubMed ID: 31852314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial.
    Adachi M; Goldfrad C; Jacques L; Nishimura Y
    Respir Med; 2016 Nov; 120():78-86. PubMed ID: 27817819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma.
    Mansfield L; Yiu G; Sakov A; Liu S; Caracta C
    Allergy Asthma Proc; 2017 Jul; 38(4):264-276. PubMed ID: 28540844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind trial evaluating the efficacy and safety of fluticasone propionate and fluticasone propionate/salmeterol delivered via multidose dry powder inhalers in patients with persistent asthma aged 12 years and older.
    Raphael G; Yiu G; Sakov A; Liu S; Caracta C
    J Asthma; 2018 Jun; 55(6):640-650. PubMed ID: 28763243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations.
    Donohue JF; Worsley S; Zhu CQ; Hardaker L; Church A
    Respir Med; 2015 Jul; 109(7):870-81. PubMed ID: 26006754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study.
    Bousquet J; Barnes N; Gibbs M; Gul N; Tomkins SA; Zhou X; Cho YJ; Park HS; Busse W; Zhong N
    BMC Pulm Med; 2017 Apr; 17(1):75. PubMed ID: 28454528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of the Efficacy of Once-Daily Fluticasone Furoate/Vilanterole with Twice-Daily Fluticasone Propionate/Salmeterol in Elderly Asthmatics.
    Ishiura Y; Fujimura M; Shiba Y; Ohkura N; Hara J; Abo M; Kasahara K
    Drug Res (Stuttg); 2018 Jan; 68(1):38-44. PubMed ID: 28926855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial.
    Płoszczuk A; Bosheva M; Spooner K; McIver T; Dissanayake S
    Ther Adv Respir Dis; 2018; 12():1753466618777924. PubMed ID: 29857783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma.
    Murray CS; Custovic A; Lowe LA; Aldington S; Williams M; Beasley R; Woodcock A
    Allergy Asthma Proc; 2010; 31(5):415-21. PubMed ID: 20929609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.
    Condemi JJ; Goldstein S; Kalberg C; Yancey S; Emmett A; Rickard K
    Ann Allergy Asthma Immunol; 1999 Apr; 82(4):383-9. PubMed ID: 10227337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.
    Stempel DA; Raphiou IH; Kral KM; Yeakey AM; Emmett AH; Prazma CM; Buaron KS; Pascoe SJ;
    N Engl J Med; 2016 May; 374(19):1822-30. PubMed ID: 26949137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.